1. Home
  2. CM vs SYK Comparison

CM vs SYK Comparison

Compare CM & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Imperial Bank of Commerce

CM

Canadian Imperial Bank of Commerce

HOLD

Current Price

$106.06

Market Cap

86.8B

Sector

N/A

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$346.37

Market Cap

127.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CM
SYK
Founded
1867
1941
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.8B
127.0B
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
CM
SYK
Price
$106.06
$346.37
Analyst Decision
Buy
Buy
Analyst Count
2
14
Target Price
$107.50
$417.50
AVG Volume (30 Days)
1.6M
1.9M
Earning Date
05-28-2026
04-30-2026
Dividend Yield
2.83%
1.01%
EPS Growth
N/A
8.25
EPS
N/A
8.40
Revenue
N/A
$25,116,000,000.00
Revenue This Year
$23.09
$9.85
Revenue Next Year
$4.65
$8.36
P/E Ratio
$15.80
$41.34
Revenue Growth
N/A
11.16
52 Week Low
$58.00
$319.32
52 Week High
$105.00
$404.87

Technical Indicators

Market Signals
Indicator
CM
SYK
Relative Strength Index (RSI) 71.34 54.18
Support Level $90.69 $328.23
Resistance Level N/A $375.26
Average True Range (ATR) 1.76 7.69
MACD 1.19 3.05
Stochastic Oscillator 99.13 80.79

Price Performance

Historical Comparison
CM
SYK

About CM Canadian Imperial Bank of Commerce

Canadian Imperial Bank of Commerce is Canada's fifth-largest bank with over CAD 1.1 trillion in assets at the end of fiscal 2025. It operates four business segments: Canadian retail and business banking, Canadian commercial banking and wealth management, US commercial banking and wealth management, and capital markets. It serves approximately 14 million personal banking and business customers, primarily in Canada and the US.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: